Is a complete CRON research report available?

No complete published report is available for Cronos Group Inc. (CRON) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cronos Group Inc. (CRON)

NASDAQ: CRON · USD

$3.36

-0.03 (-0.7%)· Recorded snapshot

Market cap	1.2B
Revenue (ttm)	179.1M
Net income (ttm)	70M
EPS (ttm)	$0.19
Shares out	368.4M
P/E (trailing)	18.0x
P/E (forward)	17.3x
Volume	490,177
Beta	1.20

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001656472
Company name	Cronos Group Inc.
Country	Canada
Country code	US
CUSIP number	22717L101
Earnings date	2026-11-05
Earnings time	bmo
Employees	610
Employees change	151
Employees growth	32.9%
Enterprise value	$486.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
Is SPAC	No
ISIN number	CA22717L1013
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.2B
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$3.36
Price currency	USD
Sector	Healthcare
SIC code	2833
Stock price date	2026-10-28
Symbol	CRON
Website	https://thecronosgroup.com

Metric

Value

Amount currency

USD

CIK code

0001656472

Company name

Cronos Group Inc.

Country

Canada

Country code

CUSIP number

22717L101

Earnings date

2026-11-05

Earnings time

bmo

Employees

610

Employees change

151

Employees growth

32.9%

Enterprise value

$486.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Is SPAC

ISIN number

CA22717L1013

Last 10-K release date

2026-02-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.2B

Market cap category

Small-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$3.36

Price currency

USD

Sector

Healthcare

SIC code

2833

Stock price date

2026-10-28

Symbol

CRON

Website

https://thecronosgroup.com

Metric	Value
Earnings yield	5.56%
EV/Earnings	7.09x
EV/EBITDA	41.75x
EV/FCF	9.96x
EV/Sales	2.77x
FCF / EV yield	10.04%
FCF yield	3.98%
Forward EV/Sales	1.91x
Forward P/E	17.27x
Forward P/S	4.81x
Graham number	3.55152
Graham upside	6.02%
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(FCF - SBC) ratio	28.85x
P/(OCF - SBC) ratio	23.34x
P/B ratio	1.12x
P/E ratio	17.99x
P/FCF ratio	25.12x
P/OCF ratio	20.83x
P/S ratio	6.99x
Price / tangible book value	1.26x
Price/EBITDA ratio	105.33x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

5.56%

EV/Earnings

7.09x

EV/EBITDA

41.75x

EV/FCF

9.96x

EV/Sales

2.77x

FCF / EV yield

10.04%

FCF yield

3.98%

Forward EV/Sales

1.91x

Forward P/E

17.27x

Forward P/S

4.81x

Graham number

3.55152

Graham upside

6.02%

Industry forward P/E

13.86x

Industry P/E

173.47x

P/(FCF - SBC) ratio

28.85x

P/(OCF - SBC) ratio

23.34x

P/B ratio

1.12x

P/E ratio

17.99x

P/FCF ratio

25.12x

P/OCF ratio

20.83x

P/S ratio

6.99x

Price / tangible book value

1.26x

Price/EBITDA ratio

105.33x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-1.03%
EBITDA margin	6.63%
FCF margin	27.82%
Gross margin	43.02%
Operating margin	-1.03%
Pretax margin	38.23%
Profit margin	39.08%
Profit per employee	$114,720
Profitable quarters	2
Revenue per employee	$293,585
ROA	-0.1%
ROA (5Y)	-3.85%
ROCE	-0.16%
ROE	7.05%
ROE (5Y)	-4.78%
ROIC	-0.59%
SBC / revenue	3.6%
Tax / revenue	-5.99%

Metric

Value

EBIT margin

-1.03%

EBITDA margin

6.63%

FCF margin

27.82%

Gross margin

43.02%

Operating margin

-1.03%

Pretax margin

38.23%

Profit margin

39.08%

Profit per employee

$114,720

Profitable quarters

Revenue per employee

$293,585

ROA

-0.1%

ROA (5Y)

-3.85%

ROCE

-0.16%

ROE

7.05%

ROE (5Y)

-4.78%

ROIC

-0.59%

SBC / revenue

3.6%

Tax / revenue

-5.99%

Metric	Value
EPS growth	282.07%
EPS growth (QoQ)	136.91%
EPS growth quarters	2
EPS growth years	0
FCF growth (QoQ)	146.82%
Gross profit growth	58.98%
Gross profit growth (Q)	95.42%
Gross profit growth 3Y	94.75%
Net income growth	278.49%
Net income growth (QoQ)	133.31%
Net income growth quarters	2
Net income growth years	0
OCF growth	199.89%
OCF growth (Q)	752.02%
OCF growth (QoQ)	120.32%
Revenue growth	37.46%
Revenue growth (Q)	58.44%
Revenue growth (QoQ)	17.25%
Revenue growth 10Y	58.46%
Revenue growth 3Y	30.3%
Revenue growth 5Y	25.89%
Revenue growth quarters	12
Revenue growth years	9

Metric

Value

EPS growth

282.07%

EPS growth (QoQ)

136.91%

EPS growth quarters

EPS growth years

FCF growth (QoQ)

146.82%

Gross profit growth

58.98%

Gross profit growth (Q)

95.42%

Gross profit growth 3Y

94.75%

Net income growth

278.49%

Net income growth (QoQ)

133.31%

Net income growth quarters

Net income growth years

OCF growth

199.89%

OCF growth (Q)

752.02%

OCF growth (QoQ)

120.32%

Revenue growth

37.46%

Revenue growth (Q)

58.44%

Revenue growth (QoQ)

17.25%

Revenue growth 10Y

58.46%

Revenue growth 3Y

30.3%

Revenue growth 5Y

25.89%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-10.2M
Depreciation and amortization	$13.7M
EBIT	$-1.8M
EBITDA	$11.9M
EPS	$0.19
FCF per share	$0.14
Financing cash flow	$-48.4M
Free cash flow	$49.8M
Free cash flow minus SBC	$43.4M
Gross profit	$77M
Income taxes	$-10.7M
Investing cash flow	$-340.5M
Net cash flow	$-327.4M
Net income	$70M
Operating cash flow minus SBC	$53.6M
Operating income	$-1.8M
Revenue	$179.1M
Stock-based compensation	$6.5M

Metric

Value

Capital expenditures

$-10.2M

Depreciation and amortization

$13.7M

EBIT

$-1.8M

EBITDA

$11.9M

EPS

$0.19

FCF per share

$0.14

Financing cash flow

$-48.4M

Free cash flow

$49.8M

Free cash flow minus SBC

$43.4M

Gross profit

$77M

Income taxes

$-10.7M

Investing cash flow

$-340.5M

Net cash flow

$-327.4M

Net income

$70M

Operating cash flow minus SBC

$53.6M

Operating income

$-1.8M

Revenue

$179.1M

Stock-based compensation

$6.5M

Metric	Value
Altman Z-Score	10.97
Book value per share	$2.88
Debt / EBITDA	0.1
Debt / equity	0
Debt / FCF	0.03
Goodwill	$64.1M
Long-term assets	$267.8M
Long-term liabilities	$6.1M
Net cash (debt)	$795.7M
Net cash / market cap	63.6%
Net cash growth	-4.41%
Net debt / EBITDA	-66.99
Net debt / equity	-0.71
Net debt / FCF	-15.97
Piotroski F-Score	4
Property, plant and equipment	$142.8M
Shareholders' equity	$1.1B
Tangible book value	$996.5M
Tangible book value per share	$2.69
Total assets	$1.2B
Total cash	$797M
Total debt	$1.3M
Total liabilities	$62.4M
WACC	10.86%

Metric

Value

Altman Z-Score

10.97

Book value per share

$2.88

Debt / EBITDA

0.1

Debt / equity

Debt / FCF

0.03

Goodwill

$64.1M

Long-term assets

$267.8M

Long-term liabilities

$6.1M

Net cash (debt)

$795.7M

Net cash / market cap

63.6%

Net cash growth

-4.41%

Net debt / EBITDA

-66.99

Net debt / equity

-0.71

Net debt / FCF

-15.97

Piotroski F-Score

Property, plant and equipment

$142.8M

Shareholders' equity

$1.1B

Tangible book value

$996.5M

Tangible book value per share

$2.69

Total assets

$1.2B

Total cash

$797M

Total debt

$1.3M

Total liabilities

$62.4M

WACC

10.86%

Metric	Value
Asset turnover	0.15
Current assets	$912M
Current liabilities	$56.4M
Current ratio	16.18
Inventory turnover	2.15
Net working capital	$58.8M
Quick ratio	15.15
Working capital	$855.7M
Working capital turnover	0.21

Metric

Value

Asset turnover

0.15

Current assets

$912M

Current liabilities

$56.4M

Current ratio

16.18

Inventory turnover

2.15

Net working capital

$58.8M

Quick ratio

15.15

Working capital

$855.7M

Working capital turnover

0.21

Metric	Value
Buyback yield / dilution	1.58%
Dividend yield	0%
Shareholder yield	1.58%

Metric

Value

Buyback yield / dilution

1.58%

Dividend yield

Shareholder yield

1.58%

Metric	Value
10Y price change	260.97%
10Y return CAGR	13.7%
10Y total return	260.97%
150-day SMA	$2.93
1D price change	-0.74%
1M price change	-0.15%
1M total return	-0.15%
1W price change	1.68%
1W total return	1.68%
1Y price change	35.02%
1Y return CAGR	35.05%
1Y total return	35.02%
20-day SMA	$3.27
200-day SMA	$2.85
3M price change	16.61%
3M total return	16.61%
3Y price change	93.9%
3Y return CAGR	24.69%
3Y total return	93.9%
50-day SMA	$3.30
50-day SMA vs 200-day SMA	50over200
52-week high	$3.61
52-week high date	2026-08-27
52-week low	$2.28
52-week low date	2025-11-21
5Y price change	-36.96%
5Y return CAGR	-8.82%
5Y total return	-36.96%
6M price change	23.52%
6M total return	23.52%
All-time high	$25.10
All-time high date	2019-02-04
All-time low	$0.17
All-time low date	2016-07-12
Average true range (ATR)	$0.10
Average volume	838.3K
Beta (5Y)	1.2
Change from 52-week high	-7.01%
Change from 52-week low	47.15%
Change from all-time high	-86.71%
Change from all-time low	1,921.21%
Change from open	-0.59%
Day's gap	-0.15%
Dollar volume	$1.6M
High price	$3.38
Low price	$3.32
Monthly RSI	63.96
Open price	$3.38
Position in 52-week range	63.64%
Premarket change	0.07%
Premarket close	$3.38
Premarket price	$3.38
Premarket volume	2.9K
Previous close	$3.38
Price vs 150-day SMA	13.9%
Price vs 20-day SMA	2.02%
Price vs 200-day SMA	17.14%
Price vs 50-day SMA	1.09%
Relative volume	0.58
RSI	53.64
Sharpe ratio	0.85
Sharpe ratio (3Y)	0.61
Sharpe ratio (5Y)	-0.02
Sortino ratio	1.6
Sortino ratio (3Y)	1.16
Sortino ratio (5Y)	0.09
Volume	490.2K
Weekly RSI	62.89
YTD price change	26.81%
YTD total return	26.81%

Metric

Value

10Y price change

260.97%

10Y return CAGR

13.7%

10Y total return

260.97%

150-day SMA

$2.93

1D price change

-0.74%

1M price change

-0.15%

1M total return

-0.15%

1W price change

1.68%

1W total return

1.68%

1Y price change

35.02%

1Y return CAGR

35.05%

1Y total return

35.02%

20-day SMA

$3.27

200-day SMA

$2.85

3M price change

16.61%

3M total return

16.61%

3Y price change

93.9%

3Y return CAGR

24.69%

3Y total return

93.9%

50-day SMA

$3.30

50-day SMA vs 200-day SMA

50over200

52-week high

$3.61

52-week high date

2026-08-27

52-week low

$2.28

52-week low date

2025-11-21

5Y price change

-36.96%

5Y return CAGR

-8.82%

5Y total return

-36.96%

6M price change

23.52%

6M total return

23.52%

All-time high

$25.10

All-time high date

2019-02-04

All-time low

$0.17

All-time low date

2016-07-12

Average true range (ATR)

$0.10

Average volume

838.3K

Beta (5Y)

1.2

Change from 52-week high

-7.01%

Change from 52-week low

47.15%

Change from all-time high

-86.71%

Change from all-time low

1,921.21%

Change from open

-0.59%

Day's gap

-0.15%

Dollar volume

$1.6M

High price

$3.38

Low price

$3.32

Monthly RSI

63.96

Open price

$3.38

Position in 52-week range

63.64%

Premarket change

0.07%

Premarket close

$3.38

Premarket price

$3.38

Premarket volume

2.9K

Previous close

$3.38

Price vs 150-day SMA

13.9%

Price vs 20-day SMA

2.02%

Price vs 200-day SMA

17.14%

Price vs 50-day SMA

1.09%

Relative volume

0.58

RSI

53.64

Sharpe ratio

0.85

Sharpe ratio (3Y)

0.61

Sharpe ratio (5Y)

-0.02

Sortino ratio

1.6

Sortino ratio (3Y)

1.16

Sortino ratio (5Y)

0.09

Volume

490.2K

Weekly RSI

62.89

YTD price change

26.81%

YTD total return

26.81%

Metric	Value
Float	187M
Float percentage	50.75%
Shares change (QoQ)	-1.76%
Shares change (YoY)	-1.58%
Shares held by insiders	6.75%
Shares held by institutions	14.37%
Shares outstanding	368.4M
Short % of float	1.8%
Short % of shares	0.91%
Short ratio	3.9 days

Metric

Value

Float

187M

Float percentage

50.75%

Shares change (QoQ)

-1.76%

Shares change (YoY)

-1.58%

Shares held by insiders

6.75%

Shares held by institutions

14.37%

Shares outstanding

368.4M

Short % of float

1.8%

Short % of shares

0.91%

Short ratio

3.9 days

Cronos Group Inc. (CRON)

Price

Financial snapshot

Fair-value bridge

Latest news · CRON

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CRON indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CRON

Frequently asked questions